June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Augmentation of Protective Microglia Restricts Outer Retinal Degeneration and Preserves Vision
Author Affiliations & Notes
  • Chen Yu
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Eleonora M Lad
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
  • Alan Proia
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
    Pathology, Duke University School of Medicine, Durham, North Carolina, United States
  • Daniel R Saban
    Ophthalmology, Duke University School of Medicine, Durham, North Carolina, United States
    Immunology, Duke University School of Medicine, Durham, North Carolina, United States
  • Footnotes
    Commercial Relationships   Chen Yu Duke University, Code P (Patent); Eleonora Lad Roche, Code F (Financial Support); Alan Proia Novartis, Code F (Financial Support), Roche, Code F (Financial Support); Daniel Saban Roche, Code C (Consultant/Contractor), Aeri (C) , Code C (Consultant/Contractor), Novartis, Code F (Financial Support), Dompe, Code F (Financial Support), Duke University, Code P (Patent)
  • Footnotes
    Support  NIH Grant R01EY030906, VA Merit Award I01 CX002116-01, Research to Prevent Blindness (Unrestricted, Duke Eye Center), NIH Core grant P30EY005722
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 23. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chen Yu, Eleonora M Lad, Alan Proia, Daniel R Saban; Augmentation of Protective Microglia Restricts Outer Retinal Degeneration and Preserves Vision. Invest. Ophthalmol. Vis. Sci. 2022;63(7):23.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Immune processes in many forms of retinal degeneration, including age-related macular degeneration (AMD), involves migration and ectopic accumulation of macrophages in the subretinal space. Recently, we described a unique subtype of bona fide microglia that are dominant in the subretinal space in mouse models of retinal degeneration. These subretinal microglia are transcriptionally reprogrammed and contribute to protecting the retina pigment epithelium (RPE) from damage caused by degeneration. These findings now prompt new investigations aimed at identifying the molecular players underlying this protective response.

Methods : We utilized single cell RNA-seq and compared subretinal microglia in four distinct disease mouse models that represent key pathobiological aspects of outer retinal degenerative diseases. These individual models included the light damage model, the sodium iodate induced RPE injury model, rhodopsin-P23H knockin mice, and an advanced aging model of 2-year-old mice. Global and microglial-conditional knockout mice were generated to assess the contributions of microglia in mediating this protective response.

Results : We found that the transcriptional signature of subretinal microglia is consistent among all mouse models studied. Confocal microscopy revealed that subretinal Iba1+ cells dominantly expressed markers of this signature in all mouse models. Likewise, these markers were also observed in human postmortem retinas with intermediate to advanced AMD, whereas few positive cells were found in either healthy or early AMD subjects. Moreover, we showed that genetic inhibition of this protection exacerbated death of photoreceptors, loss of RPE integrity and impairment of visual function in multiple models. Importantly, the protective activity by microglia was compromised during retinal degeneration, whereas pharmacological bolstering of subretinal microglia protected the retina from degeneration and better-preserved the RPE integrity and vision in mice.

Conclusions : Our findings demonstrate a general signature of subretinal microglia in mice and the possible relevance of this microglial population in forms of human AMD. These results provide a novel focal point for therapeutic strategies in vision preservation with retinal degenerative diseases.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×